Index – Merck Annual Report 2021
     Merck Group – Key figures
     Key share price data
     Net sales
     Reconciliation EBITDA pre
     Operating cash flow
     Reconciliation of net income to net income pre
     Research and development costs
     Biopharma Pipeline
     Market changes by business sectors
     Merck Group – Forecast against actual business developments
     Life Science – Forecast against actual business developments
     Healthcare – Forecast against actual business developments
     Electronics – Forecast against actual business developments
     Corporate and Other – Forecast against actual business developments
     Merck Group – Key figures
     Merck Group – Net sales by business sector
     Merck Group – Net sales by region
     Merck Group – Consolidated Income Statement
     Merck Group – Balance sheet structure
     Merck Group – Net financial debt
     Merck Group – Reconciliation of net financial debt
     Merck Group – Key balance sheet figures
     Life Science – Key figures
     Life Science – Net sales by business unit
     Life Science – Net sales by region
     Life Science – Reconciliation EBITDA pre
     Healthcare – Key figures
     Healthcare – Net sales by major product lines/products
     Healthcare – Product sales and organic growth1 of Rebif®, Glucophage® and Erbitux® by region
     Healthcare – Net sales region
     Healthcare – Reconciliation EBITDA pre
     Electronics – Key figures
     Electronics – Net sales by business unit
     Electronics – Net sales by region
     Electronics – Reconciliation EBITDA pre
     Corporate and Other – Key figures
     Probability of occurrence
     Degree of impact
     Merck Group – Forecast
     Life Science – Forecast
     Healthcare – Forecast
     Electronics – Forecast
     Total greenhouse gas emissions (Scope 1 and 2 of the GHG Protocol)
     Other relevant indirect greenhouse gas emissions (Scope 3 of the GHG Protocol)
     Significant spills
     Energy consumption
     Total number of employees
     Employee age by region
     Internationality of employees
     New employees
     Staff turnover
     Number of employees by hierarchical level
     Work-related accidents
     Human rights violations
     Data Privacy
     Reported compliance violations
     Environmental Objective "Climate Change Mitigation"
     Pension entitlements – Defined contribution obligations
     Pension entitlements – Defined benefit obligations
     Profit after tax of the E. Merck Group
     Profit sharing 2021 summary
     Merck LTIP Tranche 2021 allocation
     Merck LTIP Tranche 2018 target achievement
     Merck LTIP Tranche 2019 target achievement
     Merck LTIP 2019 summary
     Merck LTIP 2018 summary
     Parameters for the sustainability factor for the 2022 tranche of the LTIP
     Share Ownership Guideline
     Compensation awarded or due – Belén Garijo
     Compensation awarded or due – Stefan Oschmann
     Compensation awarded or due – Kai Beckmann
     Compensation awarded or due – Peter Guenter
     Compensation awarded or due – Matthias Heinzel
     Compensation awarded or due – Marcus Kuhnert
     Compensation awarded or due – Stefan Oschmann 2
     Compensation awarded or due – Udit Batra
     Compensation awarded or due – Walter Galinat
     Former Member of the Executive Board 1
     Former Member of the Executive Board 2
     Former Member of the Executive Board 3
     Former Member of the Executive Board 4
     Former Member of the Executive Board 5
     Former Member of the Executive Board 6
     Former Member of the Executive Board 7
     Former Member of the Executive Board 8
     Former Member of the Executive Board 9
     Former Member of the Executive Board 10
     Pension payments
     Overall compensation limit
     Compensation awarded or due
     Comparative presentation
     Merck KGaA – Assets and debt
     Merck KGaA – Net sales by business sector
     Merck KGaA – Group sales and sales to third parties
     Merck KGaA – Net sales outside of and in Germany
     Merck KGaA – Results of operations
     Merck KGaA – Assets
     Merck KGaA – Equity and liabilities
     Merck KGaA – Research and development expenses
     Merck KGaA – Personnel
     Consolidated income statement
     Consolidated statement of comprehensive income
     Consolidated balance sheet
     Consolidated cash flow statement
     Consolidated statement of changes in net equity – 2021
     Consolidated statement of changes in net equity– 2020
     Exchange rates
     Discretionary decisions and sources of estimation uncertainty
     Changes in the scope of consolidation
     Segment reporting by business sector – 2021
     Segment reporting by business sector – 2020
     Segment reporting by country and region – 2021
     Segment reporting by country and region – 2020
     Reconciliation of Segment results to the profit before income tax
     Adjustments in the operating result
     Adjustments disclosed in the consolidated income statement – 2021
     Adjustments disclosed in the consolidated income statement – 2020
     Net sales by key product lines/products – Life Science
     Net sales by key product lines/products – Healthcare
     Net sales by key product lines/products – Electronics
     Net sales by business sector from contracts with customers – 2021
     Net sales by business sector from contracts with customers – 2020
     Future net sales – 2021
     Future net sales – 2020
     Refund liabilities – 2021
     Refund liabilities – 2020
     Marketing and selling expenses
     Other operating income
     Other operating expenses
     Income taxes
     Tax reconciliation
     Deferred taxes income statement
     Tax loss carryforwards
     Deferred taxes balance sheet
     Significant measurement assumptions
     Change of key assumptions before recognition of an impairment loss
     Goodwill
     Other intangible assets
     Other intangible assets – attributable to the business sectors
     Property, plant and equipment – Useful lives
     Property, plant and equipment
     Property, plant and equipment – Additions
     Reconciliation of right-of-use assets from leases – 2021
     Reconciliation of right-of-use assets from leases – 2020
     Leases affecting the consolidated income statement
     Payments from leases shown in the consolidated cash flow statement
     Lease liabilities – Expected maturities – 2021
     Lease liabilities – Expected maturities – 2020
     Other non-financial assets
     Inventories
     Trade and other receivables
     Contract assets
     Other provisions
     Contingent liabilities
     Other non-financial liabilities
     Contract liabilities
     Number of employees
     Personnel expenses
     Provisions for employee benefits
     Defined benefit obligations – Actuarial parameters
     Defined benefit obligations – Actuarial parameters – 2021
     Defined benefit obligations – Actuarial parameters – 2020
     Value recognized in the consolidated balance sheet for pensions
     Defined benefit obligations – Types of benefits – 2021
     Defined benefit obligations – Types of benefits – 2020
     Net defined benefit liability – 2021
     Net defined benefit liability – 2020
     Fair value of plan assets 
     Employer contributions to plan assets – 2021
     Employer contributions to plan assets – 2020
     Other provisions for employees
     Share-based payments – Impact on non-current provisions
     Merck Share Units (MSUs) for individual tranches
     Retained earnings
     Gains/losses recognized in equity
     Net profit/loss transfer between E. Merck KG and Merck KGaA
     Profit carried forward between E. Merck KG and Merck KGaA
     Appropriation of profits and changes in reserves
     Cash and cash equivalents
     Other financial assets
     Financial debt and reconciliation to net financial debt
     Bank financing commitments
     Other financial liabilities
     Nominal amounts of derivative exposures
     Fair values of derivative exposures – 2021
     Fair values of derivative exposures – 2020
     Potential netting volume of the reported derivative assets and liabilities – 2021
     Potential netting volume of the reported derivative assets and liabilities – 2020
     Hedging instruments
     Finance income and expenses
     Interest income and expenses